What is the dosage, frequency, and duration for polyTussin (dextromethorphan) in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PolyTussin Dosing for Adults

For adults, PolyTussin (containing dextromethorphan 15 mg per 5 mL) should be dosed at 1 teaspoonful (5 mL) every 4 to 6 hours, not exceeding 6 teaspoonfuls (30 mL) in 24 hours, for short-term symptomatic relief of acute cough lasting no more than 1-2 weeks. 1

Standard Dosing Regimen

Frequency and Amount:

  • Adults and children ≥12 years: 1 teaspoonful (5 mL) every 4-6 hours 1
  • Maximum daily dose: 6 teaspoonfuls (30 mL) in 24 hours 1
  • This provides 15 mg dextromethorphan per dose, with a maximum of 90 mg daily 1

Duration of Treatment:

  • Use for acute cough only, typically 1-2 weeks maximum 2, 3
  • If cough persists beyond 1 week, stop use and consult a physician 1
  • If cough persists beyond 3 weeks, discontinue and perform full diagnostic workup rather than continuing antitussive therapy 3

Important Clinical Considerations

Dosing Limitations:

  • The standard over-the-counter dextromethorphan dose of 15 mg per 5 mL is often subtherapeutic 2, 3
  • Maximum cough reflex suppression occurs at 60 mg dextromethorphan (which would require 20 mL of PolyTussin), though this exceeds the labeled single-dose recommendation 2, 4
  • Caution with higher doses: PolyTussin contains additional active ingredients (dexbrompheniramine 2 mg and phenylephrine 7.5 mg per 5 mL) that may cause adverse effects at higher doses 1

When to Stop and Reassess:

  • Beyond 14 days: Discontinue and evaluate for alternative diagnoses such as post-viral cough, pertussis, pneumonia, or chronic conditions 3
  • Beyond 21 days (3 weeks): Cough is no longer "acute" and requires full diagnostic workup rather than continued antitussive therapy 3

Contraindications and Precautions

Do Not Use If: 1

  • Currently taking or stopped within 2 weeks a monoamine oxidase inhibitor (MAOI) 1
  • Have breathing problems such as emphysema or chronic bronchitis 1
  • Have glaucoma 1
  • Have enlarged prostate with urination difficulty 1
  • Have chronic cough from smoking, asthma, or emphysema 1
  • Have productive cough with excessive phlegm 1
  • Have heart disease, high blood pressure, or thyroid disease 1

Stop Use and Seek Medical Attention If: 1

  • Nervousness, dizziness, or sleeplessness occur 1
  • Cough or nasal congestion persists for more than 1 week 1
  • Cough recurs or is accompanied by fever, rash, or persistent headache 1
  • New symptoms develop 1

Common Pitfalls to Avoid

  • Do not prescribe for extended periods without reassessing the underlying cause 3
  • Avoid using as a substitute for proper diagnosis when cough becomes chronic 3
  • Do not exceed maximum daily dose due to risk of adverse effects from all three active ingredients 1
  • Be aware of sedation risk: The antihistamine component (dexbrompheniramine) causes marked drowsiness; patients should avoid alcohol, driving, and operating machinery 1
  • Monitor for drug interactions: The phenylephrine component may interact with other medications and affect blood pressure 1

Alternative Considerations

For more effective cough suppression without combination product risks:

  • Consider dextromethorphan alone at 30-60 mg for better efficacy 2, 4
  • Simple home remedies like honey and lemon may be equally effective for benign viral cough 2, 4
  • Menthol inhalation provides acute but short-lived relief 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cough Management in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medications for Acute Cough in the Emergency Department

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.